0001640334-19-000793.txt : 20190509
0001640334-19-000793.hdr.sgml : 20190509
20190509160548
ACCESSION NUMBER: 0001640334-19-000793
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190502
FILED AS OF DATE: 20190509
DATE AS OF CHANGE: 20190509
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tesi Raymond Joseph
CENTRAL INDEX KEY: 0001767280
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38793
FILM NUMBER: 19810485
MAIL ADDRESS:
STREET 1: 476 MASSACHUSETTS AVE, UNIT 2
CITY: BOSTON
STATE: MA
ZIP: 02118
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Inmune Bio, Inc.
CENTRAL INDEX KEY: 0001711754
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 475205835
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1224 PROSPECT STREET
STREET 2: SUITE 150
CITY: LA JOLLA
STATE: CA
ZIP: 92037
BUSINESS PHONE: 8589643720
MAIL ADDRESS:
STREET 1: 1224 PROSPECT STREET
STREET 2: SUITE 150
CITY: LA JOLLA
STATE: CA
ZIP: 92037
4/A
1
form4a.xml
FORM 4 A
X0306
4/A
2019-05-02-06:00
2019-05-06-06:00
false
0001711754
Inmune Bio, Inc.
INMB
0001767280
Tesi Raymond Joseph
C/O INMUNE BIO INC.
1224 PROSPECT STREET, SUITE 150
LA JOLLA
CA
92037
true
true
true
false
President & CEO
Common Stock
2019-05-02-06:00
4
P
false
11100
9
A
1526933
D
Includes 11,100 shares of the Issuer's common stock acquired by the Reporting Person in connection with a private placement effected as of May 2, 2019.
This amendment was filed to correct the purchase price of the securities acquired by the Reporting Person.
/s/ Raymond Joseph Tessi
2019-05-09-06:00